MedDataX Logo

Laser Therapy and Temporomandibular Disorders

NCT ID: NCT05620758

Last Updated: 2022-12-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-30

Study Completion Date

2023-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

TMD involves a set of multiple clinical manifestations where the pain is prevalent. Treatment ideally should be noninvasive and innocuous such as photobiomodulation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

TMD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nd YAG laser

Group Type EXPERIMENTAL

Nd YAG laser

Intervention Type OTHER

patients from those diagnosed with TMD will receive Nd YAG laser 1064 nm

Diode laser 980 nm

Group Type EXPERIMENTAL

diode laser (980 nm)

Intervention Type OTHER

patients from those diagnosed with TMD will receive a diode laser (980 nm)

Diode laser 940 nm

Group Type EXPERIMENTAL

diode laser (940 nm)

Intervention Type OTHER

patients from those diagnosed with TMD will receive a diode laser (940 nm)

Diode laser 660 nm

Group Type EXPERIMENTAL

diode laser (660 nm)

Intervention Type OTHER

patients from those diagnosed with TMD will receive a diode laser (660 nm)

Diode laser 635 nm

Group Type EXPERIMENTAL

diode laser (635 nm)

Intervention Type OTHER

patients from those diagnosed with TMD will receive a diode laser (635 nm)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nd YAG laser

patients from those diagnosed with TMD will receive Nd YAG laser 1064 nm

Intervention Type OTHER

diode laser (980 nm)

patients from those diagnosed with TMD will receive a diode laser (980 nm)

Intervention Type OTHER

diode laser (940 nm)

patients from those diagnosed with TMD will receive a diode laser (940 nm)

Intervention Type OTHER

diode laser (660 nm)

patients from those diagnosed with TMD will receive a diode laser (660 nm)

Intervention Type OTHER

diode laser (635 nm)

patients from those diagnosed with TMD will receive a diode laser (635 nm)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pain at TMJ area.
* Pain at masseter and temporalis muscles.
* Age ranges between 20 and 40 years old.
* Presence of full or nearly full complement of natural teeth

Exclusion Criteria

* Patients who have radiographic evidence of degenerative conditions of TMJ.
* Patients under current dental or physical therapy that could affect TMD.
* History of recent trauma.
* The presence of systemic diseases (i.e. rheumatoid arthritis, osteoarthritis).
* Pregnant and lactating females
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hams Hamed Abdelrahman

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hams Hamed Abdelrahman

Assistant lecturer of DPH and Clinical statistician

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alexandria Faculty of Dentistry

Alexandria, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nermeen A Rady, phd

Role: CONTACT

Phone: 01223349577

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nermeen A Rady, phd

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TMD_Laser_2022

Identifier Type: -

Identifier Source: org_study_id